Schroder Investment Management Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.2M | Buy |
336,173
+71,888
| +27% | +$2.61M | 0.01% | 603 |
|
|
2025
Q1 | $10M | Sell |
264,285
-111,876
| -30% | -$4.23M | 0.01% | 639 |
|
|
2024
Q4 | $15.9M | Buy |
376,161
+193,296
| +106% | +$8.17M | 0.02% | 565 |
|
|
2024
Q3 | $9.95M | Sell |
182,865
-174,573
| -49% | -$9.5M | 0.01% | 662 |
|
|
2024
Q2 | $14.7M | Buy |
357,438
+102,360
| +40% | +$4.21M | 0.02% | 548 |
|
|
2024
Q1 | $11.9M | Buy |
255,078
+5,026
| +2% | +$235K | 0.01% | 617 |
|
|
2023
Q4 | $12M | Buy |
+250,052
| New | +$12M | 0.02% | 601 |
|